- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 99,600 | 23.08.24 09:04:07 | +0,800 | +0,81% | 99,850 | 99,920 | 99,600 | 98,800 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 1.066,500 | 23.08.24 08:03:23 | +3,500 | +0,33% | 1.067,000 | 1.073,000 | 1.066,500 | 1.063,000 |
